Fresenius SE & Co. KGaA (FRE.DE)
EUR 34.19
(0.41%)
EUR 34.19
(0.41%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.51 Billion EUR | -47.92% |
| 2022 | 4.83 Billion EUR | 14.58% |
| 2021 | 4.21 Billion EUR | 6.92% |
| 2020 | 3.94 Billion EUR | 8.59% |
| 2019 | 3.63 Billion EUR | 12.9% |
| 2018 | 3.21 Billion EUR | -1.05% |
| 2017 | 3.25 Billion EUR | 1.98% |
| 2016 | 3.18 Billion EUR | 11.5% |
| 2015 | 2.86 Billion EUR | 22.59% |
| 2014 | 2.33 Billion EUR | 15.84% |
| 2013 | 2.01 Billion EUR | 9.46% |
| 2012 | 1.84 Billion EUR | 7.16% |
| 2011 | 1.71 Billion EUR | 21.69% |
| 2010 | 1.41 Billion EUR | 14.25% |
| 2009 | 1.23 Billion EUR | 9.58% |
| 2008 | 1.12 Billion EUR | 28.8% |
| 2007 | 875 Million EUR | 14.98% |
| 2006 | 761 Million EUR | 4.68% |
| 2005 | 727 Million EUR | 17.45% |
| 2004 | 619 Million EUR | -3.58% |
| 2003 | 642 Million EUR | -2.58% |
| 2002 | 659 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.63 Billion EUR | 4.85% |
| 2024 Q2 | 2.65 Billion EUR | 0.64% |
| 2023 Q1 | 4.94 Billion EUR | 2.36% |
| 2023 Q3 | 2.66 Billion EUR | -46.93% |
| 2023 Q4 | 2.51 Billion EUR | -5.48% |
| 2023 FY | 2.51 Billion EUR | -47.92% |
| 2023 Q2 | 5.01 Billion EUR | 1.44% |
| 2022 Q2 | 4.69 Billion EUR | 6.19% |
| 2022 Q4 | 4.83 Billion EUR | -3.32% |
| 2022 FY | 4.83 Billion EUR | 14.58% |
| 2022 Q1 | 4.42 Billion EUR | 4.86% |
| 2022 Q3 | 4.99 Billion EUR | 6.43% |
| 2021 Q4 | 4.21 Billion EUR | -0.92% |
| 2021 Q1 | 4.09 Billion EUR | 3.73% |
| 2021 FY | 4.21 Billion EUR | 6.92% |
| 2021 Q2 | 4.19 Billion EUR | 2.57% |
| 2021 Q3 | 4.25 Billion EUR | 1.43% |
| 2020 Q2 | 4.02 Billion EUR | 7.7% |
| 2020 Q3 | 4.03 Billion EUR | 0.12% |
| 2020 Q4 | 3.94 Billion EUR | -2.16% |
| 2020 Q1 | 3.73 Billion EUR | 2.92% |
| 2020 FY | 3.94 Billion EUR | 8.59% |
| 2019 Q3 | 3.68 Billion EUR | 2.36% |
| 2019 FY | 3.63 Billion EUR | 12.9% |
| 2019 Q2 | 3.6 Billion EUR | 2.62% |
| 2019 Q1 | 3.5 Billion EUR | 9.04% |
| 2019 Q4 | 3.63 Billion EUR | -1.44% |
| 2018 Q2 | 3.07 Billion EUR | 4.84% |
| 2018 FY | 3.21 Billion EUR | -1.05% |
| 2018 Q4 | 3.21 Billion EUR | 1.23% |
| 2018 Q3 | 3.17 Billion EUR | 3.35% |
| 2018 Q1 | 2.93 Billion EUR | -9.78% |
| 2017 Q1 | 3.27 Billion EUR | 2.6% |
| 2017 FY | 3.25 Billion EUR | 1.98% |
| 2017 Q4 | 3.25 Billion EUR | 2.78% |
| 2017 Q3 | 3.16 Billion EUR | -0.97% |
| 2017 Q2 | 3.19 Billion EUR | -2.35% |
| 2016 Q1 | 2.87 Billion EUR | 0.35% |
| 2016 Q2 | 2.98 Billion EUR | 4.04% |
| 2016 Q3 | 3.05 Billion EUR | 2.21% |
| 2016 Q4 | 3.18 Billion EUR | 4.49% |
| 2016 FY | 3.18 Billion EUR | 11.5% |
| 2015 Q4 | 2.86 Billion EUR | 4.0% |
| 2015 FY | 2.86 Billion EUR | 22.59% |
| 2015 Q3 | 2.75 Billion EUR | 3.66% |
| 2015 Q1 | 2.64 Billion EUR | 13.5% |
| 2015 Q2 | 2.65 Billion EUR | 0.19% |
| 2014 Q2 | 2.27 Billion EUR | 4.45% |
| 2014 FY | 2.33 Billion EUR | 15.84% |
| 2014 Q4 | 2.33 Billion EUR | -0.21% |
| 2014 Q3 | 2.33 Billion EUR | 2.68% |
| 2014 Q1 | 2.18 Billion EUR | 8.24% |
| 2013 FY | 2.01 Billion EUR | 9.46% |
| 2013 Q1 | 1.96 Billion EUR | 6.58% |
| 2013 Q2 | 1.99 Billion EUR | 1.84% |
| 2013 Q3 | 1.98 Billion EUR | -0.55% |
| 2013 Q4 | 2.01 Billion EUR | 1.41% |
| 2012 Q2 | 1.85 Billion EUR | 3.23% |
| 2012 FY | 1.84 Billion EUR | 7.16% |
| 2012 Q4 | 1.84 Billion EUR | 4.78% |
| 2012 Q3 | 1.75 Billion EUR | -5.34% |
| 2012 Q1 | 1.79 Billion EUR | 4.66% |
| 2011 FY | 1.71 Billion EUR | 21.69% |
| 2011 Q2 | 1.54 Billion EUR | 3.96% |
| 2011 Q1 | 1.48 Billion EUR | 5.53% |
| 2011 Q4 | 1.71 Billion EUR | 6.51% |
| 2011 Q3 | 1.61 Billion EUR | 4.13% |
| 2010 FY | 1.41 Billion EUR | 14.25% |
| 2010 Q4 | 1.41 Billion EUR | 0.93% |
| 2010 Q3 | 1.39 Billion EUR | -6.99% |
| 2010 Q2 | 1.5 Billion EUR | 10.19% |
| 2010 Q1 | 1.36 Billion EUR | 10.45% |
| 2009 Q4 | 1.23 Billion EUR | 0.0% |
| 2009 FY | 1.23 Billion EUR | 9.58% |
| 2008 FY | 1.12 Billion EUR | 28.8% |
| 2007 FY | 875 Million EUR | 14.98% |
| 2006 FY | 761 Million EUR | 4.68% |
| 2005 FY | 727 Million EUR | 17.45% |
| 2004 FY | 619 Million EUR | -3.58% |
| 2003 FY | 642 Million EUR | -2.58% |
| 2002 FY | 659 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 2.17 Billion EUR | -15.502% |
| LIMES Schlosskliniken AG | 80.12 Thousand EUR | -3141163.245% |
| M1 Kliniken AG | 45.52 Million EUR | -5428.675% |
| Maternus-Kliniken Aktiengesellschaft | 586 Thousand EUR | -429422.184% |
| MEDICLIN Aktiengesellschaft | 7.29 Million EUR | -34396.634% |
| RHÖN-KLINIKUM Aktiengesellschaft | 34.21 Million EUR | -7256.638% |
| VITA 34 AG | 3.4 Million EUR | -73820.705% |